{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:07:43Z","timestamp":1788671263677,"version":"build-2803163510"},"reference-count":22,"publisher":"Korean Association of Internal Medicine","issue":"1","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI17C1050"],"award-info":[{"award-number":["HI17C1050"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea"}],"content-domain":{"domain":["kjim.org"],"crossmark-restriction":true},"short-container-title":["Korean J Intern Med"],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:p>Background\/Aims: Patients with liver cirrhosis (LC) have low levels of branchedchain amino acids (BCAAs). There is accumulating evidence that BCAAs have anti- fibrotic effects in cirrhosis. This study is aimed to evaluate the effect of BCAAs on the function and phenotype of activated hepatic stellate cells (HSCs).Methods: LX-2, an immortalized human stellate cell line, was used in in vitro experiments. LX-2 cells were exposed to transforming growth factor \u03b21 (TGF-\u03b21) and BCAAs or to valine, leucine, and isoleucine, which are components of BCAAs. Activation of the TGF-\u03b2 signaling pathway in LX-2 cells was observed using real- time quantitative polymerase chain reaction and Western blotting.Results: The increased expression of snail family transcriptional repressor 1 (SNAI1) was observed in LX-2 cells activated by TGF-\u03b21. After BCAA treatment, its expression was significantly decreased at the mRNA level. The increased expression of Col1\u03b11 and TIMP2 at the mRNA level and alpha smooth muscle actin at the protein level in activated LX-2 cells decreased after BCAA treatment. Among the BCAA components, leucine and valine significantly abrogated TGF-\u03b2-induced activation of LX-2 cells. BCAA treatment led to the decreased phosphorylation of Smad2 and p38 proteins, which are markers for Smad and Smad-independent p38 mitogen-activated protein kinase signaling pathways, respectively.Conclusions: BCAA treatment can improve hepatic fibrosis by directly affecting the activated state of hepatic stellate cells through inhibition of the TGF-\u03b2 signaling pathway. Among BCAA components, leucine and valine mainly abrogated TGF-\u03b2-induced activation of HSCs. Our results suggest that BCAA may be used to attenuate the progression of liver fibrosis.<\/jats:p>","DOI":"10.3904\/kjim.2020.197","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T04:55:16Z","timestamp":1599022516000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.3904\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells"],"prefix":"10.3904","volume":"37","author":[{"given":"Hae Lim","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hoon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonhee","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-7842","authenticated-orcid":true,"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2270","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9865-y"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/b978-1-4377-0881-3.00005-x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.001"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2009.06.027"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24412"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12297"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077899"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00141.2010"},{"key":"ref9","first-page":"156","volume-title":"TGF-beta-induced epithelial to mesenchymal transition","author":"Xu","year":"2009"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(03)00323-8"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006580"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051429"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15304"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111419"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022129"},{"key":"ref16","first-page":"3573","volume-title":"Non-Smad TGF-beta signals","author":"Moustakas","year":"2005"},{"key":"ref17","first-page":"128","volume-title":"Non-Smad pathways in TGF-beta signaling","author":"Zhang","year":"2009"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15566"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290257"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.171"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/131.3.861s"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu6103981"}],"container-title":["The Korean Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/kjim.org\/upload\/kjim-2020-197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/kjim.org\/journal\/view.php?doi=10.3904\/kjim.2020.197","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/kjim.org\/upload\/kjim-2020-197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:46:45Z","timestamp":1641282405000},"score":1,"resource":{"primary":{"URL":"http:\/\/kjim.org\/journal\/view.php?doi=10.3904\/kjim.2020.197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.3904\/kjim.2020.197","relation":{},"ISSN":["1226-3303","2005-6648"],"issn-type":[{"value":"1226-3303","type":"print"},{"value":"2005-6648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"assertion":[{"value":"2020-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}